The Bioavailability of Mycoprotein

University of Exeter

Status: Completed

Conditions: Availability of Mycoprotein

Treatments: Other: Mycoprotein ingestion

Study type: Interventional

Funder types: Other

Identifiers

NCT04233411

157758

Details and patient eligibility

About

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

Enrollment: 12 patients

Sex: Male

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy and aged 18-40 y
• BMI between 18 and 30

Exclusion criteria

• On medication
• Family history of metabolic disease
• Diagnosed with any metabolic or cardiovascular conditions
• BMI < 18 or > 30

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

12 participants in 5 patient groups

Milk

Active Comparator group

Description:

Acute ingestion of 20 g milk protein

Treatment:

Other: Mycoprotein ingestion

20g

Experimental group

Description:

Acute ingestion of 20 g mycoprotein

Treatment:

Other: Mycoprotein ingestion

40g

Experimental group

Description:

Acute ingestion of 40 g mycoprotein

Treatment:

Other: Mycoprotein ingestion

60g

Experimental group

Description:

Acute ingestion of 60 g mycoprotein

Treatment:

Other: Mycoprotein ingestion

80g

Experimental group

Description:

Acute ingestion of 60 g mycoprotein

Treatment:

Other: Mycoprotein ingestion